We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
DOFIDAZ (Glenmark Pharmaceuticals Australia Pty Ltd)
Product name
DOFIDAZ
Date registered
Evaluation commenced
Decision date
Approval time
160 (255 working days)
Active ingredients
diclofenac sodium
Registration type
New generic medicine
Indication
Management of actinic keratoses.